Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07530419) titled 'Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)' on April 8.

Study Type: Observational [Patient Registry]

Primary Sponsor: Seoul National University Hospital

Condition: Metabolic Dysfunction-Associated Steatotic Liver Disease Fatty Liver Liver Fibrosis

Intervention: Device: Samsung Medison HERA W12 (R30) with S-Shearwave platform

Recruitment Status: Not recruiting

Date of First Enrollment: April 10, 2026

Target Sample Size: 95

Countries of Recruitment: South Korea

To know more, visit https://clinicaltrials.gov/study/NCT07530419

Disclaimer: Curated by HT Syndication....